IGF1 and neoplasm: hMSCs also play a role in cancer progression by releasing angiogenic factors, such as IGF-1, SDF-1, and PDGF, which promote tumor neovascularization, enhance tumor engraftment, and suppress immune responses to cancer cells [16, 17, 19, 20, 22, 24, 40–42].